Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Incyte Corporation (INCY) A Good Stock To Buy?

Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They generate significant returns for investors to justify their large fees and they allocate a lot of time and employ a complex analysis to determine the best stocks to invest in. A particularly interesting group of stocks that hedge funds like is the small-caps. The huge amount of capital does not allow hedge funds to invest a lot in small-caps, but our research showed that their most popular small-cap ideas are less efficiently priced and generate stronger returns than their large- and mega-cap picks and the broader market. That is why we follow the hedge fund activity in the small-cap space.

Incyte Corporation (NASDAQ:INCY) shares haven’t seen a lot of action during the third quarter. Overall, hedge fund sentiment was unchanged. The stock was in 37 hedge funds’ portfolios at the end of the third quarter of 2018. At the end of this article we will also compare INCY to other stocks including Entergy Corporation (NYSE:ETR), Lincoln National Corporation (NYSE:LNC), and Synopsys, Inc. (NASDAQ:SNPS) to get a better sense of its popularity.

To most investors, hedge funds are assumed to be unimportant, outdated financial tools of the past. While there are greater than 8,000 funds with their doors open today, Our experts look at the elite of this group, around 700 funds. Most estimates calculate that this group of people control most of the hedge fund industry’s total capital, and by keeping an eye on their matchless stock picks, Insider Monkey has unearthed a number of investment strategies that have historically outrun the S&P 500 index. Insider Monkey’s flagship hedge fund strategy outstripped the S&P 500 index by 6 percentage points a year since its inception in May 2014 through early November 2018. We were able to generate large returns even by identifying short candidates. Our portfolio of short stocks lost 24% since February 2017 (through December 3rd) even though the market was up nearly 23% during the same period. We just shared a list of 11 short targets in our latest quarterly update.

Millennium Management, Catapult Capital Management

We’re going to take a look at the new hedge fund action surrounding Incyte Corporation (NASDAQ:INCY).

How are hedge funds trading Incyte Corporation (NASDAQ:INCY)?

At Q3’s end, a total of 37 of the hedge funds tracked by Insider Monkey held long positions in this stock, no change from the second quarter of 2018. Below, you can check out the change in hedge fund sentiment towards INCY over the last 13 quarters. With hedge funds’ positions undergoing their usual ebb and flow, there exists a few notable hedge fund managers who were upping their stakes significantly (or already accumulated large positions).

No of Hedge Funds with INCY Positions

Among these funds, Baker Bros. Advisors held the most valuable stake in Incyte Corporation (NASDAQ:INCY), which was worth $2366.1 million at the end of the third quarter. On the second spot was Matrix Capital Management which amassed $318.9 million worth of shares. Moreover, Citadel Investment Group, Millennium Management, and Two Sigma Advisors were also bullish on Incyte Corporation (NASDAQ:INCY), allocating a large percentage of their portfolios to this stock.

Seeing as Incyte Corporation (NASDAQ:INCY) has faced declining sentiment from hedge fund managers, it’s safe to say that there lies a certain “tier” of funds who sold off their entire stakes by the end of the third quarter. It’s worth mentioning that Samuel Isaly’s OrbiMed Advisors dumped the biggest stake of all the hedgies monitored by Insider Monkey, comprising about $29.3 million in stock. Steven Boyd’s fund, Armistice Capital, also sold off its stock, about $28.7 million worth. These transactions are important to note, as total hedge fund interest stayed the same (this is a bearish signal in our experience).

Let’s go over hedge fund activity in other stocks similar to Incyte Corporation (NASDAQ:INCY). We will take a look at Entergy Corporation (NYSE:ETR), Lincoln National Corporation (NYSE:LNC), Synopsys, Inc. (NASDAQ:SNPS), and Genuine Parts Company (NYSE:GPC). All of these stocks’ market caps match INCY’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
ETR 27 1329530 6
LNC 33 1001611 5
SNPS 30 1204856 2
GPC 21 292208 5
Average 27.75 957051 4.5

View table here if you experience formatting issues.

As you can see these stocks had an average of 27.75 hedge funds with bullish positions and the average amount invested in these stocks was $957 million. That figure was $3.26 billion in INCY’s case. Lincoln National Corporation (NYSE:LNC) is the most popular stock in this table. On the other hand Genuine Parts Company (NYSE:GPC) is the least popular one with only 21 bullish hedge fund positions. Compared to these stocks Incyte Corporation (NASDAQ:INCY) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.